HMGCS2 and bladder transitional cell carcinoma: The results show that HMGCS2 has the similar pattern in a variety of tumors (Figures 2E and 2F), including liver hepatocellular carcinoma (LIHC), bladder urothelial carcinoma (BLCA), brain lower-grade glioma (LGG), and KIRC.